Emkay

Accent Microcell Ltd.

NSE : ACCENTMICSM BSE : ISIN CODE : INE0Q5D01013Industry : Pharmaceuticals

494.452.40
(0.49%)

30 Jul 2026 | 03:44

Open (Rs.)

500.00

Prev. close (Rs.)

492.05

Bid Price(Qty.)

0.00(0)

Offer Pr.(Qty.)

494.45(2500)

Volume (Rs.)

31000.00

Today's High / Low

500.00

490.00

52 Week High / Low

530.00

238.00

Company Info

Management

Mr. Vasant PatelChairman & Executive Director
Mr. Ghanshyam PatelManaging Director & CFO
Mr. Nitin PatelExecutive Director
Mr. Vinod PatelExecutive Director
Mr. Chintan BhattIndependent Director

Incorporation Year

10/04/2012

Registered Address

Registered Office : 314, Shangrilla Arcade, Shyamal Cross Road, , Anandnagar Road,Satellite,
Ahmedabad, Gujarat - 380015
Tel: Tel: 079-40042367
Fax:
Email : info@accentmicrocell.com
Website : http://www.accentmicrocell.com

Registrar Office

KFin Technologies Ltd.
Selenium Tower B, Plot No. 31-32,
Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad - 500032Tel: 040-67161500
Fax: 23420814

Listing

NSE , NSE

Financials

Owners Fund (₹ Cr.)

Net Block (₹ Cr.)

Curr. Assets (₹ Cr.)

Investments (₹ Cr.)

Note: Values are based on Consolidated Data

Shareholding Pattern

News

Please Login to view Research & Trading Ideas

Emkay Trading Ideas

Please Login to view Research & Trading Ideas

Peer Comparison

Company Name	Price ( ₹ )	Book Value ( ₹ )	EPS ( ₹ )	Market Cap. (₹ Cr.)	P/E (x)	Year End	Sales (₹ Cr.)	PAT (₹ Cr.)
+ Aarey Drugs & Pharmaceut...	77.12	53.02	1.40	218.67	55.13	202603	472.27	3.97
+ Aarti Drugs Ltd.	412.80	169.70	21.36	3,767.63	19.33	202603	2,565.31	194.92
+ Aarti Pharmalabs Ltd.	674.30	234.30	19.27	6,114.54	35.00	202603	1,819.44	174.71
+ Abbott India Ltd.	27,555.00	2,246.75	730.39	58,552.45	37.73	202603	6,929.05	1,552.02
+ Accent Microcell Ltd.	494.45	114.84	18.28	1,186.14	27.05	202603	349.03	43.86

MF Holding

No Data Available

Announcements

Date of Meeting	Purpose
12/05/2026	Audited Results, Dividend & Others
14/10/2025	Quarterly Results & Others
22/08/2025	Dividend & Others
29/05/2025	To Consider Fund Raising & Other
09/05/2025	Audited Results & Others